US20090221816A1 - Process for the Asymmetric Epoxidation of Olefins - Google Patents
Process for the Asymmetric Epoxidation of Olefins Download PDFInfo
- Publication number
- US20090221816A1 US20090221816A1 US12/464,933 US46493309A US2009221816A1 US 20090221816 A1 US20090221816 A1 US 20090221816A1 US 46493309 A US46493309 A US 46493309A US 2009221816 A1 US2009221816 A1 US 2009221816A1
- Authority
- US
- United States
- Prior art keywords
- formula
- arylalkyl
- aryl
- alkyl
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 27
- 150000001336 alkenes Chemical class 0.000 title abstract description 13
- 238000006735 epoxidation reaction Methods 0.000 title abstract description 9
- 150000003303 ruthenium Chemical class 0.000 claims abstract description 10
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 61
- 150000001875 compounds Chemical class 0.000 claims description 44
- 239000001257 hydrogen Substances 0.000 claims description 32
- 229910052739 hydrogen Inorganic materials 0.000 claims description 32
- -1 trialkylsiloxyalkyl Chemical group 0.000 claims description 32
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 28
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 27
- 125000003118 aryl group Chemical group 0.000 claims description 26
- 125000000217 alkyl group Chemical group 0.000 claims description 23
- 150000002431 hydrogen Chemical group 0.000 claims description 21
- 125000004432 carbon atom Chemical group C* 0.000 claims description 19
- 229910052799 carbon Inorganic materials 0.000 claims description 13
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 11
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 9
- 125000003545 alkoxy group Chemical group 0.000 claims description 9
- 229910052736 halogen Inorganic materials 0.000 claims description 9
- 150000002367 halogens Chemical group 0.000 claims description 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 9
- 239000012327 Ruthenium complex Substances 0.000 claims description 8
- 239000003446 ligand Substances 0.000 claims description 8
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 7
- 125000002947 alkylene group Chemical group 0.000 claims description 7
- 125000004122 cyclic group Chemical group 0.000 claims description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 6
- MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 claims description 6
- 229920000642 polymer Polymers 0.000 claims description 6
- 239000003905 agrochemical Substances 0.000 claims description 5
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims description 5
- 239000000543 intermediate Substances 0.000 claims description 5
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 4
- 125000001188 haloalkyl group Chemical group 0.000 claims description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 4
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 4
- 239000001301 oxygen Substances 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- 229910001413 alkali metal ion Inorganic materials 0.000 claims description 3
- 229910001420 alkaline earth metal ion Inorganic materials 0.000 claims description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 150000001721 carbon Chemical group 0.000 claims 8
- ORTFAQDWJHRMNX-UHFFFAOYSA-N hydroxidooxidocarbon(.) Chemical group O[C]=O ORTFAQDWJHRMNX-UHFFFAOYSA-N 0.000 claims 3
- 239000003054 catalyst Substances 0.000 abstract description 15
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 34
- 239000007800 oxidant agent Substances 0.000 description 28
- 230000001590 oxidative effect Effects 0.000 description 28
- 150000003254 radicals Chemical class 0.000 description 25
- PJANXHGTPQOBST-VAWYXSNFSA-N trans-stilbene Chemical compound C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 20
- 0 [1*]C1([2*])OC1([3*])[4*] Chemical compound [1*]C1([2*])OC1([3*])[4*] 0.000 description 16
- WJJMNDUMQPNECX-UHFFFAOYSA-L dipicolinate(2-) Chemical compound [O-]C(=O)C1=CC=CC(C([O-])=O)=N1 WJJMNDUMQPNECX-UHFFFAOYSA-L 0.000 description 15
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 14
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 12
- 238000007429 general method Methods 0.000 description 10
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000000654 additive Substances 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000011541 reaction mixture Substances 0.000 description 8
- PJANXHGTPQOBST-UHFFFAOYSA-N trans-Stilbene Natural products C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 6
- 229910052707 ruthenium Inorganic materials 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- ARCJQKUWGAZPFX-KBPBESRZSA-N S-trans-stilbene oxide Chemical compound C1([C@H]2[C@@H](O2)C=2C=CC=CC=2)=CC=CC=C1 ARCJQKUWGAZPFX-KBPBESRZSA-N 0.000 description 5
- AWMVMTVKBNGEAK-UHFFFAOYSA-N Styrene oxide Chemical compound C1OC1C1=CC=CC=C1 AWMVMTVKBNGEAK-UHFFFAOYSA-N 0.000 description 5
- 230000000996 additive effect Effects 0.000 description 5
- LAXRNWSASWOFOT-UHFFFAOYSA-J (cymene)ruthenium dichloride dimer Chemical compound [Cl-].[Cl-].[Cl-].[Cl-].[Ru+2].[Ru+2].CC(C)C1=CC=C(C)C=C1.CC(C)C1=CC=C(C)C=C1 LAXRNWSASWOFOT-UHFFFAOYSA-J 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 150000002924 oxiranes Chemical class 0.000 description 4
- 239000002243 precursor Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 description 3
- MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methylbutan-2-ol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 description 3
- WBOBVMSCGJYBMF-UHFFFAOYSA-L O=C([O-])C1=CC=CC(C(=O)[O-])=N1.[CH2+][CH2-] Chemical compound O=C([O-])C1=CC=CC(C(=O)[O-])=N1.[CH2+][CH2-] WBOBVMSCGJYBMF-UHFFFAOYSA-L 0.000 description 3
- MKYQPGPNVYRMHI-UHFFFAOYSA-N Triphenylethylene Chemical group C=1C=CC=CC=1C=C(C=1C=CC=CC=1)C1=CC=CC=C1 MKYQPGPNVYRMHI-UHFFFAOYSA-N 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 description 2
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 2
- FERMVCULDZOVOJ-UHFFFAOYSA-N 2-(1-oxidopyridin-2-ylidene)pyridin-1-ium 1-oxide Chemical compound [O-]N1C=CC=CC1=C1[N+](=O)C=CC=C1 FERMVCULDZOVOJ-UHFFFAOYSA-N 0.000 description 2
- BTOVVHWKPVSLBI-UHFFFAOYSA-N 2-methylprop-1-enylbenzene Chemical compound CC(C)=CC1=CC=CC=C1 BTOVVHWKPVSLBI-UHFFFAOYSA-N 0.000 description 2
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 2
- WCMSFBRREKZZFL-UHFFFAOYSA-N 3-cyclohexen-1-yl-Benzene Chemical compound C1CCCC(C=2C=CC=CC=2)=C1 WCMSFBRREKZZFL-UHFFFAOYSA-N 0.000 description 2
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical group N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N C=CC Chemical compound C=CC QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- QROGIFZRVHSFLM-QHHAFSJGSA-N [(e)-prop-1-enyl]benzene Chemical compound C\C=C\C1=CC=CC=C1 QROGIFZRVHSFLM-QHHAFSJGSA-N 0.000 description 2
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 description 2
- XYLMUPLGERFSHI-UHFFFAOYSA-N alpha-Methylstyrene Chemical compound CC(=C)C1=CC=CC=C1 XYLMUPLGERFSHI-UHFFFAOYSA-N 0.000 description 2
- 150000007854 aminals Chemical class 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- UXIGLKSQMPZUGZ-UHFFFAOYSA-L disodium;pyridine-2,6-dicarboxylate Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC(C([O-])=O)=N1 UXIGLKSQMPZUGZ-UHFFFAOYSA-L 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 2
- 238000000769 gas chromatography-flame ionisation detection Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- 125000005246 nonafluorobutyl group Chemical group FC(F)(F)C(F)(F)C(F)(F)C(F)(F)* 0.000 description 2
- 125000002524 organometallic group Chemical group 0.000 description 2
- 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 150000003333 secondary alcohols Chemical class 0.000 description 2
- 150000003509 tertiary alcohols Chemical class 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- 238000010626 work up procedure Methods 0.000 description 2
- UFDULEKOJAEIRI-UHFFFAOYSA-N (2-acetyloxy-3-iodophenyl) acetate Chemical compound CC(=O)OC1=CC=CC(I)=C1OC(C)=O UFDULEKOJAEIRI-UHFFFAOYSA-N 0.000 description 1
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 description 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 description 1
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 description 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
- 125000004955 1,4-cyclohexylene group Chemical group [H]C1([H])C([H])([H])C([H])([*:1])C([H])([H])C([H])([H])C1([H])[*:2] 0.000 description 1
- KTZVZZJJVJQZHV-UHFFFAOYSA-N 1-chloro-4-ethenylbenzene Chemical compound ClC1=CC=C(C=C)C=C1 KTZVZZJJVJQZHV-UHFFFAOYSA-N 0.000 description 1
- JWVTWJNGILGLAT-UHFFFAOYSA-N 1-ethenyl-4-fluorobenzene Chemical compound FC1=CC=C(C=C)C=C1 JWVTWJNGILGLAT-UHFFFAOYSA-N 0.000 description 1
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 description 1
- LJYNYLMLKGMXCC-UHFFFAOYSA-N 2,2,3-triphenyloxirane Chemical compound C=1C=CC=CC=1C1(C=2C=CC=CC=2)OC1C1=CC=CC=C1 LJYNYLMLKGMXCC-UHFFFAOYSA-N 0.000 description 1
- RPVFYIHRKXUWDA-UHFFFAOYSA-N 2,2,6,6-tetramethyl-1-(2,2,6,6-tetramethylpiperidin-1-yl)oxypiperidine Chemical compound CC1(C)CCCC(C)(C)N1ON1C(C)(C)CCCC1(C)C RPVFYIHRKXUWDA-UHFFFAOYSA-N 0.000 description 1
- GIMKHGWDFQQNSB-UHFFFAOYSA-N 2,2-dimethyl-3-phenyloxirane Chemical compound CC1(C)OC1C1=CC=CC=C1 GIMKHGWDFQQNSB-UHFFFAOYSA-N 0.000 description 1
- IBWLXNDOMYKTAD-UHFFFAOYSA-N 2-(4-chlorophenyl)oxirane Chemical compound C1=CC(Cl)=CC=C1C1OC1 IBWLXNDOMYKTAD-UHFFFAOYSA-N 0.000 description 1
- ICVNPQMUUHPPOK-UHFFFAOYSA-N 2-(4-fluorophenyl)oxirane Chemical compound C1=CC(F)=CC=C1C1OC1 ICVNPQMUUHPPOK-UHFFFAOYSA-N 0.000 description 1
- IGDFTUPVJILWDI-UHFFFAOYSA-N 2-[2-(4,5-dihydro-1,3-oxazol-2-yl)pyridin-3-yl]-4,5-dihydro-1,3-oxazole Chemical compound O1CCN=C1C1=CC=CN=C1C1=NCCO1 IGDFTUPVJILWDI-UHFFFAOYSA-N 0.000 description 1
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 1
- SDLOAJBYHVVDQI-UHFFFAOYSA-N 2-methyl-2,3-diphenyloxirane Chemical compound C=1C=CC=CC=1C1(C)OC1C1=CC=CC=C1 SDLOAJBYHVVDQI-UHFFFAOYSA-N 0.000 description 1
- MRXPNWXSFCODDY-UHFFFAOYSA-N 2-methyl-2-phenyloxirane Chemical compound C=1C=CC=CC=1C1(C)CO1 MRXPNWXSFCODDY-UHFFFAOYSA-N 0.000 description 1
- YVCOJTATJWDGEU-UHFFFAOYSA-N 2-methyl-3-phenyloxirane Chemical compound CC1OC1C1=CC=CC=C1 YVCOJTATJWDGEU-UHFFFAOYSA-N 0.000 description 1
- DUDYJVLITCQGCP-UHFFFAOYSA-N 6-phenyl-7-oxabicyclo[4.1.0]heptane Chemical compound O1C2CCCCC21C1=CC=CC=C1 DUDYJVLITCQGCP-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- LFTLOKWAGJYHHR-UHFFFAOYSA-N N-methylmorpholine N-oxide Chemical compound CN1(=O)CCOCC1 LFTLOKWAGJYHHR-UHFFFAOYSA-N 0.000 description 1
- VFEDNNQIBTVBDE-UHFFFAOYSA-H N1=C(C=CC=C1C(=O)[O-])C(=O)[O-].[Ru+3].N1=C(C=CC=C1C(=O)[O-])C(=O)[O-].N1=C(C=CC=C1C(=O)[O-])C(=O)[O-].[Ru+3] Chemical class N1=C(C=CC=C1C(=O)[O-])C(=O)[O-].[Ru+3].N1=C(C=CC=C1C(=O)[O-])C(=O)[O-].N1=C(C=CC=C1C(=O)[O-])C(=O)[O-].[Ru+3] VFEDNNQIBTVBDE-UHFFFAOYSA-H 0.000 description 1
- FGVPREMQEVVSSX-HXFSWNFUSA-L O=C1O[Ru]234(OC(=O)C5=N2C1=CC=C5)N1=C(C=CC=C1C1=N3[C@@H](C2=CC3=C(C=CC=C3)C=C2)CCO1)C1=N4[C@@H](C2=CC3=C(C=CC=C3)C=C2)CCO1 Chemical compound O=C1O[Ru]234(OC(=O)C5=N2C1=CC=C5)N1=C(C=CC=C1C1=N3[C@@H](C2=CC3=C(C=CC=C3)C=C2)CCO1)C1=N4[C@@H](C2=CC3=C(C=CC=C3)C=C2)CCO1 FGVPREMQEVVSSX-HXFSWNFUSA-L 0.000 description 1
- GIIWGCBLYNDKBO-UHFFFAOYSA-N Quinoline 1-oxide Chemical compound C1=CC=C2[N+]([O-])=CC=CC2=C1 GIIWGCBLYNDKBO-UHFFFAOYSA-N 0.000 description 1
- 239000002262 Schiff base Substances 0.000 description 1
- 150000004753 Schiff bases Chemical class 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Chemical group 0.000 description 1
- OVZXISBUYCEVEV-SEYXRHQNSA-N [(z)-1-phenylprop-1-en-2-yl]benzene Chemical compound C=1C=CC=CC=1C(/C)=C\C1=CC=CC=C1 OVZXISBUYCEVEV-SEYXRHQNSA-N 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 125000002015 acyclic group Chemical group 0.000 description 1
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001414 amino alcohols Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
- 159000000032 aromatic acids Chemical class 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 150000005840 aryl radicals Chemical class 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 150000001244 carboxylic acid anhydrides Chemical class 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000002933 cyclohexyloxy group Chemical group C1(CCCCC1)O* 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- AQYSYJUIMQTRMV-UHFFFAOYSA-N hypofluorous acid Chemical group FO AQYSYJUIMQTRMV-UHFFFAOYSA-N 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- MPQXHAGKBWFSNV-UHFFFAOYSA-N oxidophosphanium Chemical class [PH3]=O MPQXHAGKBWFSNV-UHFFFAOYSA-N 0.000 description 1
- CFHIDWOYWUOIHU-UHFFFAOYSA-N oxomethyl Chemical compound O=[CH] CFHIDWOYWUOIHU-UHFFFAOYSA-N 0.000 description 1
- AQSJGOWTSHOLKH-UHFFFAOYSA-N phosphite(3-) Chemical class [O-]P([O-])[O-] AQSJGOWTSHOLKH-UHFFFAOYSA-N 0.000 description 1
- ILVXOBCQQYKLDS-UHFFFAOYSA-N pyridine N-oxide Chemical compound [O-][N+]1=CC=CC=C1 ILVXOBCQQYKLDS-UHFFFAOYSA-N 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 125000004469 siloxy group Chemical group [SiH3]O* 0.000 description 1
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical class [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 1
- ARCJQKUWGAZPFX-UHFFFAOYSA-N stilbene oxide Chemical compound O1C(C=2C=CC=CC=2)C1C1=CC=CC=C1 ARCJQKUWGAZPFX-UHFFFAOYSA-N 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- OVZXISBUYCEVEV-UHFFFAOYSA-N trans-alpha-methylstilbene Natural products C=1C=CC=CC=1C(C)=CC1=CC=CC=C1 OVZXISBUYCEVEV-UHFFFAOYSA-N 0.000 description 1
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0046—Ruthenium compounds
- C07F15/0053—Ruthenium compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D301/00—Preparation of oxiranes
- C07D301/02—Synthesis of the oxirane ring
- C07D301/03—Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds
- C07D301/12—Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds with hydrogen peroxide or inorganic peroxides or peracids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D301/00—Preparation of oxiranes
- C07D301/02—Synthesis of the oxirane ring
- C07D301/03—Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds
- C07D301/19—Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds with organic hydroperoxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/04—Compounds containing oxirane rings containing only hydrogen and carbon atoms in addition to the ring oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/08—Compounds containing oxirane rings with hydrocarbon radicals, substituted by halogen atoms, nitro radicals or nitroso radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Definitions
- the present invention relates to a catalyst based on ruthenium complexes and to a process for the asymmetric epoxidation of olefins using catalysts based on ruthenium complexes.
- Olefins are readily available and inexpensive raw materials for industrial applications. They can be converted by oxidation into epoxides which are in turn of great importance as versatile intermediates in the synthesis of active compounds and fine chemicals (cosmetics industry, polymer industry, etc). Chiral epoxides are particularly valuable since they make it possible to obtain numerous structural elements, e.g. chiral diols or chiral amino alcohols, which frequently occur, in particular, in natural products and biologically active compounds. The most efficient and most economical method of synthesizing chiral epoxides is the catalytic, asymmetric epoxidation of olefins.
- Mezefti et al. discloses that olefins can be epoxidized in the presence of ruthenium catalysts and using hydrogen peroxide as oxidant, but the enantioselectivities of at most 42% are unsatisfactory and the yields are in most cases too low for industrial applications.
- R 8 is hydrogen, alkyl or arylalkyl, with the reaction being carried out in the presence of a ruthenium complex which bears as ligands both compounds of the formula (V)
- R 9 is hydrogen, halogen, hydroxy, hydroxycarbonyl, alkoxycarbonyl, alkoxy, alkyl, arylalkyl or aryl and L 1 and L 2 are each, independently of one another, a radical of the formula (VI-a) or a radical of the formula (VI-b), but are preferably identical radicals of the formula (VI-a) or of the formula (VI-b)
- R 10a , R 10b and R 11 are each, independently of one another, alkyl, alkoxyalkyl, trialkylsiloxyalkyl, alkoxycarbonyl, arylalkyl or aryl or R 10a and R 11 or R 10a and R 10b are part of a cyclic radical having a total of from 5 to 16 carbon atoms and R 11 and/or in each case one or both radicals R 10a and/or R 10b , preferably in each case one or both radicals R 10a and/or R 10b , may also be hydrogen
- stereoisomerically enriched means that one diastereomer or enantiomer is present in a higher relative proportion than the other diastereomers or the other enantiomer.
- the present invention encompasses all definitions of radicals, parameters and explanations above and below, in general terms or in preferred ranges, in any combination with one another, i.e. also between the respective ranges and preferred ranges.
- aryl preferably refers, unless indicated individually, to carbocyclic aromatic radicals having from 6 to 24 skeletal carbon atoms or heteroaromatic radicals having from 5 to 24 skeletal carbon atoms in which no, one, two or three skeletal carbon atoms per ring, but at least one skeletal carbon atom in the total molecule, can be replaced by heteroatoms selected from the group consisting of nitrogen, sulphur and oxygen.
- carbocyclic aromatic radicals or heteroaromatic radicals can be substituted by up to five identical or different substituents per ring selected from the group consisting of hydroxy, fluorine, nitro, cyano, free or protected formyl, C 1 -C 12 -alkyl, C 5 -C 14 -aryl, C 6 -C 15 -arylalkyl, —PO—[(C 1 -C 8 )-alkyl] 2 , —PO—[(C 5 -C 14 )-aryl] 2 , —PO—[(C 1 -C 8 )-alkyl)(C 5 -C 14 )-aryl)], tri(C 1 -C 8 -alkyl)siloxyl or radicals of the formulae (IIa) to (IIf).
- substituents per ring selected from the group consisting of hydroxy, fluorine, nitro, cyano, free or protected formyl, C 1 -C 12 -alkyl
- aryl is preferably phenyl, naphthyl or anthracenyl which may be substituted by one, two or three radicals selected independently from the group consisting of C 1 -C 6 -alkyl, C 5 -C 14 -aryl, C 1 -C 6 -alkoxy, C 1 -C 6 -alkoxycarbonyl, halogen, hydroxy, nitro or cyano.
- alkyl or alkylene or alkoxy is preferably, unless indicated individually, in each case independently, a straight-chain, cyclic, branched or unbranched alkyl or alkylene or alkoxy radical which may be further substituted by C 1 -C 4 -alkoxy radicals.
- alkylene part of an arylalkyl radical is preferably, unless indicated individually, in each case independently, a straight-chain, cyclic, branched or unbranched alkyl or alkylene or alkoxy radical which may be further substituted by C 1 -C 4 -alkoxy radicals.
- alkylene part of an arylalkyl radical is preferably, unless indicated individually, in each case independently, a straight-chain, cyclic, branched or unbranched alkyl or alkylene or alkoxy radical which may be further substituted by C 1 -C 4 -alkoxy radicals.
- alkylene part of an arylalkyl radical is preferably, unless
- alkyl is preferably methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, n-pentyl, cyclohexyl and n-hexyl, n-heptyl, n-octyl, isooctyl, n-decyl and n-dodecyl.
- alkylene is preferably methylene, 1,1-ethylene, 1,2-ethylene, 1,1-propylene, 1,2-propylene, 1,3-propylene, 1,1-butylene, 1,2-butylene, 2,3-butylene and 1,4-butylene, 1,5-pentylene, 1,6-hexylene, 1,1-cyclohexylene, 1,4-cyclohexylene, 1,2-cyclohexylene and 1,8-octylene.
- alkoxy is preferably methoxy, ethoxy, isopropoxy, n-propoxy, n-butoxy, tert-butoxy and cyclohexyloxy.
- arylalkyl is preferably, unless indicated individually, in each case independently, a straight-chain, cyclic, branched or unbranched alkyl radical which may be monosubstituted or polysubstituted, more preferably monosubstituted, by aryl radicals as defined above.
- haloalkyl or haloalkylene is preferably, unless indicated individually, in each case independently, a straight-chain, cyclic, branched or unbranched alkyl radical which may be monohalogenated, polyhalogenated or perhalogenated by halogen atoms selected independently from the group consisting of fluorine, chlorine, bromine and iodide.
- C 1 -C 8 -haloalkyl is preferably trifluoromethyl, trichloromethyl, 2,2,2-trifluoroethyl, pentafluoroethyl and nonafluorobutyl;
- C 1 -C 8 -fluoroalkyl is trifluoromethyl, 2,2,2-trifluoroethyl, pentafluoroethyl and nonafluorobutyl.
- Protected formyl is a formyl radical which is protected by conversion into an aminal, acetal or a mixed aminal-acetal, with the aminals, acetals and mixed aminal-acetals being able to be acyclic or cyclic.
- R 1 , R 2 , R 3 and R 4 are each preferably, independently of one another, hydrogen, C 1 -C 8 -alkyl, C 5 -C 14 -aryl, C 6 -C 15 -arylalkyl, C 1 -C 8 -haloalkyl or two of the radicals R 1 , R 2 , R 3 and R 4 are together part of a 3- to 7-membered ring having a total of from 3 to 16 carbon atoms.
- R 8 is preferably hydrogen or C 3 -C 6 -alkyl, more preferably hydrogen or tert-butyl and most preferably hydrogen.
- R 9 is preferably hydrogen, halogen, C 1 -C 4 -alkoxy, C 1 -C 4 -alkyl, phenyl, more preferably hydrogen or phenyl.
- L 1 and L 2 in the formula (V) are identical radicals of the formula (VI-a) or (VI-b).
- radicals R 10a and/or R 10b each being, independently of one another, hydrogen, methyl or phenyl. Particular preference is given to in each case one of the radicals R 10a and/or R 10b being methyl or phenyl and the second radical R 10a and/or R 10b and, if applicable, the two other radicals R 10a or R 10b being hydrogen, or one radical R 10a being hydrogen and the second radical R 10a together with R 11 forming an indanediyl group. More preferably, R 10a in the formula (VI-a) and R 10a and R 10b in the formula (VI-b) are each hydrogen.
- the radical R 11 is preferably methyl, isopropyl, tert-butyl, 2-naphthyl, phenyl, 2-chlorophenyl, benzyl, hydroxymethyl, tributylsiloxymethyl, 2-tributylsiloxyethyl or methoxycarbonyl.
- R 12 is preferably hydrogen, hydroxy, C 1 -C 4 -alkoxy or phenyl, more preferably hydrogen.
- n is preferably 0 or 1 and more preferably denotes one substitutent in the 4 position.
- Preferred ruthenium complexes are complexes of the formula (VIII)
- Examples of such compounds of the formula (V) are 4-Chloro-2,6-bis[4′-(S)-phenyloxazolin-2′-yl]pyridine, 4-phenyl-2,6-bis[4′-(S)-phenyl-oxazolin-2′-yl]pyridine, 2,6-bis[(R)-4′-(1′′-naphthyl)-5′,6′-dihydro-4′H-[1′,3′]oxazin-2′-yl]pyridine and 2,6-bis[(R)-4′-(2′′-naphthyl)-5′,6′-dihydro-4′H-[1′,3′]oxazin-2′-yl]pyridine.
- the process of the invention is carried out in the presence of organic solvents, in particular secondary or tertiary alcohols, aprotic polar solvents, ketones, chlorinated hydrocarbons and aromatic hydrocarbons.
- organic solvents in particular secondary or tertiary alcohols, aprotic polar solvents, ketones, chlorinated hydrocarbons and aromatic hydrocarbons.
- aprotic polar solvents are solvents which have a dielectric constant at 25° C. of 5 or more and a pK a based on an aqueous reference scale at 25° C. of 20 or more.
- secondary and tertiary alcohols in particular t-amyl alcohol and t-butyl alcohol, in the process of the invention.
- the reaction is, for example, carried out by placing the compounds of the formula (III) and the ruthenium complex and, if appropriate, an additive together with an organic solvent in a reaction vessel and adding the oxidant, if appropriate as a solution in a suitable organic solvent.
- a solution of the oxidant is metered into the reaction mixture over a period of from 10 minutes to 24 hours.
- reaction time can be, for example, up to 24 hours, preferably up to 5 hours and preferably up to 2 hours.
- the reaction can be carried out at temperatures of from ⁇ 20° C. to 150° C., preferably from 0 to 80° C., more preferably from 0° C. to 40° C., and most preferably from 15° C. to 30° C.
- the pressure in the reaction is not critical and can be, for example, from 0.5 to 100 bar, preferably from 0.8 to 10 bar. More preference is given to ambient pressure.
- tert-butyl hydroperoxide or hydrogen peroxide preference is given to using tert-butyl hydroperoxide or hydrogen peroxide in the process of the invention.
- the oxidant is preferably used in an amount of from 1 to 10 molar equivalents based on compounds of the formula (III), more preferably from 1 to 5 molar equivalents and most preferably from 1 to 3 molar equivalents. It may be advantageous to use the oxidant as a solution in a solvent, preferably as a solution in water.
- additives can be added to the reaction mixture.
- suitable additives include: amines, phosphites, phosphine oxides, N-methylmorpholine N-oxide, 2,2,6,6-tetramethylpiperidin-1-yl oxide, pyridines, pyridine N-oxide, imidazoles, quinoline, quinoline N-oxide, 2,2′-bipyridyl, 2,2′-bipyridyl N,N′-dioxide, ammonium salts, aromatic and aliphatic carboxylic acids, carboxylic anhydrides, (R)- or (S)-alkanesulfinamides and aromatic alcohols.
- These additives are preferably used in an amount of from 5 to 100 mol % based on compounds of the formula (III), more preferably from 10 to 50 mol % and very most preferably 20 mol %.
- the ruthenium complex can either be used as an isolated complex or be generated in situ in the reaction mixture. In the latter case, a suitable ruthenium precursor
- Isolated complexes are, for example,
- the preparation of the isolated complexes is preferably likewise carried out by combining a suitable ruthenium precursor complex such as [Ru(p-cymene)Cl 2 ] 2 , and the two ligands of the formulae (V) and (VIII) by, for example, introducing the ruthenium precursor complex with the ligand of the formula (V) into a suitable solvent in an inert gas atmosphere and adding a solution of the ligand of the formula (VII), subsequently heating the reaction mixture and isolating the ruthenium complex after work-up by means of extraction, drying and optionally subsequent chromatographic purification and/or recrystallization.
- a suitable ruthenium precursor complex such as [Ru(p-cymene)Cl 2 ] 2
- the amount of ruthenium complex used or of ruthenium precursor complex used is, for example, in the range from 0.01 to 20 mol %, preferably from 1 to 10 mol % and more preferably from 2 to 5 mol %.
- the compounds of the formula (I) which can be prepared according to the invention are particularly useful for preparing pharmaceuticals, agrochemicals, polymers or intermediates for these.
- the asymmetric epoxidation of olefins proceeds with high chemoselectivity and enantioselectivity and gives very good product yields.
- the ability to use the inexpensive oxidant hydrogen peroxide is a particular advantage.
- trans-stilbene and H 2 O 2 as oxidant in the general method gave trans-stilbene oxide in a yield of 99% and an ee of 67%.
- trans-stilbene and H 2 O 2 as oxidant and the catalyst [Ru(4-chloro-2,6-bis[4′-(S)-phenyloxazolin-2′-yl]pyridine)(pyridine-2,6-dicarboxylate)] in the general method gave trans-stilbene oxide in a yield of 93% and an ee of 71%.
- trans-stilbene and H 2 O 2 as oxidant and the catalyst [Ru(4-phenyl-2,6-bis[4′-(S)-phenyloxazolin-2′-yl]pyridine) (pyridine-2,6-dicarboxylate)] (0.025 mmol) in the general method gave trans-stilbene oxide in a yield of 97% and an ee of 69%.
- trans-stilbene and H 2 O 2 as oxidant and the catalyst [Ru(2,6-bis[4′-(S)-isopropyloxazolin-2′-yl]pyridine)(pyridine-2,6-dicarboxylate)] (0.025 mmol) in the general method gave trans-stilbene oxide in a yield of 100% and an ee of 54%.
- triphenylethylene and t-BuOOH as oxidant in a procedure analogous to Example 1 gave triphenylethylene oxide in a yield of 90% and an ee of 8%.
- trans-stilbene and H 2 O 2 as oxidant in a procedure analogous to Example 1, but with generation of the catalyst in situ from 0.0125 mol of [Ru(p-cymene)Cl 2 ] 2 , 0.025 mol of 2,6-bis[4′-(S)-phenyloxazolin-2′-yl]pyridine and 0.025 mol of disodium pyridine-2,6-dicarboxylate, gave trans-stilbene oxide in a yield of 96% and an ee of 61%.
- reaction mixture was subsequently extracted with 30 ml of CH 2 Cl 2 , the organic phase was washed with 30 ml of water, dried over MgSO 4 , filtered and the solvent was removed under reduced pressure.
- the product was recrystallized from CH 2 Cl 2 /n-hexane.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
Abstract
The present invention relates to a catalyst based on ruthenium complexes and to a process for the asymmetric epoxidation of olefins using catalysts based on ruthenium complexes.
Description
- This application is a divisional of U.S. patent application Ser. No. 11/051,279 filed Feb. 4, 2005, entitled “Process for the Asymmetric Epoxidation of Olefins”, the contents of which are hereby incorporated by reference in their entirety.
- The present invention relates to a catalyst based on ruthenium complexes and to a process for the asymmetric epoxidation of olefins using catalysts based on ruthenium complexes.
- Olefins are readily available and inexpensive raw materials for industrial applications. They can be converted by oxidation into epoxides which are in turn of great importance as versatile intermediates in the synthesis of active compounds and fine chemicals (cosmetics industry, polymer industry, etc). Chiral epoxides are particularly valuable since they make it possible to obtain numerous structural elements, e.g. chiral diols or chiral amino alcohols, which frequently occur, in particular, in natural products and biologically active compounds. The most efficient and most economical method of synthesizing chiral epoxides is the catalytic, asymmetric epoxidation of olefins.
- Mezefti et al. (Green Chemistry 1999, 1, 39-41; Organometallics 2000, 19, 4117-4126) discloses that olefins can be epoxidized in the presence of ruthenium catalysts and using hydrogen peroxide as oxidant, but the enantioselectivities of at most 42% are unsatisfactory and the yields are in most cases too low for industrial applications.
- Other ruthenium-based systems, e.g. chiral Schiff-base complexes (Kureshi et al., J. Mol. Catal. A: Chemical 1997, 124, 91-97) are likewise quite inefficient in terms of yield and stereoselectivity.
- A further process has been described by Nishiyama et al. (Chem. Commun. 1997, 1863-1864). In the epoxidation of trans-stilbene, enantioselectivities of 74% at yields of up to 63% were achieved using ruthenium-pyridine-2,6-dicarboxylate complexes having chiral bis(oxazolinyl)pyridine ligands. However, a disadvantage of this process is that bis(acetoxy)iodobenzene has to be used as reoxidant. This reagent is unattractive for industrial processes because of its high price.
- There is therefore still a need to develop a general and efficient process for the asymmetric epoxidation of olefins, which displays high chemoselectivities and enantioselectivities and also gives good product yields. At the same time, the use of a both inexpensive and environmentally friendly oxidant is desirable from an industrial point of view.
- We have now found a process for preparing stereoisomerically enriched compounds of the formula (I),
- where
- “*” is a carbon atom having an (R) or (S) configuration and R1, R2, R3 and R4 are each, independently of one another, hydrogen, alkyl, aryl, arylalkyl, haloalkyl or a radical of one of formulae (IIa) to (IIf)
-
A-B-D-E (IIa) -
A-E (IIb) -
A-SO2-E (IIc) -
A-B-SO2R6 (IId) -
A-SO3W (IIe) -
A-COW (IIf) - where, in the formulae (IIa) to (IIf)
- A is absent or is an alkylene or haloalkylene radical and
- B is absent or is oxygen or NR5, where
- R5 is nitrogen, arylalkyl or aryl, and
- D is a carbonyl group and
- E is R6, OR6, NHR7 or N(R7)2,
- where
- R6 is alkyl, arylalkyl or aryl and
- the radicals R7 are each, independently of one another, alkyl, arylalkyl or aryl or the moiety N(R7)2 is a cyclic amino radical having from 4 to 12 carbon atoms and
- W is OH, NH2, or OM, where M is an alkali metal ion, half an equivalent of an alkaline earth metal ion, an ammonium ion or an organic ammonium ion,
or two of the radicals R1, R2, R3 and R4 are together part of a 3- to 7-membered ring having a total of from 3 to 16 carbon atoms,
which is characterized in that compounds of the formula (III), - where R1, R2, R3 and R4 are each, independently of one another, as defined above,
are reacted with compounds of the formula (IV), -
R8—OOH (IV) - where R8 is hydrogen, alkyl or arylalkyl,
with the reaction being carried out in the presence of a ruthenium complex which bears as ligands both compounds of the formula (V) - where R9 is hydrogen, halogen, hydroxy, hydroxycarbonyl, alkoxycarbonyl, alkoxy, alkyl, arylalkyl or aryl and
L1 and L2 are each, independently of one another, a radical of the formula (VI-a) or a radical of the formula (VI-b), but are preferably identical radicals of the formula (VI-a) or of the formula (VI-b) - where “*1” and/or “*2” and/or “*3” are each an asymmetric carbon atom in the (R) or (S) configuration, with preference being given to “*1” being an asymmetric carbon atom in the (R) or (S) configuration and “*2” and/or “*3” likewise being able to be such a carbon atom, the arrow points to the point of bonding to the central pyridine ring and R10a, R10b and R11 are each, independently of one another, alkyl, alkoxyalkyl, trialkylsiloxyalkyl, alkoxycarbonyl, arylalkyl or aryl or R10a and R11 or R10a and R10b are part of a cyclic radical having a total of from 5 to 16 carbon atoms and R11 and/or in each case one or both radicals R10a and/or R10b, preferably in each case one or both radicals R10a and/or R10b, may also be hydrogen,
and compounds of the formula (VII) - where
- X1, X2 and X3 are each, independently of one another, N, CH or CR12 and
- R12 is hydrogen, halogen, hydroxy, hydroxycarbonyl, alkoxycarbonyl, alkoxy, alkoxyalkyl, arylalkyl or aryl and
- n is 0, 1, 2 or 3, preferably 0 or 1 and more preferably 0.
- For the purposes of the invention, stereoisomerically enriched means that one diastereomer or enantiomer is present in a higher relative proportion than the other diastereomers or the other enantiomer.
- The present invention encompasses all definitions of radicals, parameters and explanations above and below, in general terms or in preferred ranges, in any combination with one another, i.e. also between the respective ranges and preferred ranges.
- For the purposes of the present invention, aryl preferably refers, unless indicated individually, to carbocyclic aromatic radicals having from 6 to 24 skeletal carbon atoms or heteroaromatic radicals having from 5 to 24 skeletal carbon atoms in which no, one, two or three skeletal carbon atoms per ring, but at least one skeletal carbon atom in the total molecule, can be replaced by heteroatoms selected from the group consisting of nitrogen, sulphur and oxygen. Furthermore, the carbocyclic aromatic radicals or heteroaromatic radicals can be substituted by up to five identical or different substituents per ring selected from the group consisting of hydroxy, fluorine, nitro, cyano, free or protected formyl, C1-C12-alkyl, C5-C14-aryl, C6-C15-arylalkyl, —PO—[(C1-C8)-alkyl]2, —PO—[(C5-C14)-aryl]2, —PO—[(C1-C8)-alkyl)(C5-C14)-aryl)], tri(C1-C8-alkyl)siloxyl or radicals of the formulae (IIa) to (IIf). The same applies to the aryl part of an arylalkyl radical.
- For example, aryl is preferably phenyl, naphthyl or anthracenyl which may be substituted by one, two or three radicals selected independently from the group consisting of C1-C6-alkyl, C5-C14-aryl, C1-C6-alkoxy, C1-C6-alkoxycarbonyl, halogen, hydroxy, nitro or cyano.
- For the purposes of the present invention alkyl or alkylene or alkoxy is preferably, unless indicated individually, in each case independently, a straight-chain, cyclic, branched or unbranched alkyl or alkylene or alkoxy radical which may be further substituted by C1-C4-alkoxy radicals. The same applies to the alkylene part of an arylalkyl radical.
- For example, alkyl is preferably methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, n-pentyl, cyclohexyl and n-hexyl, n-heptyl, n-octyl, isooctyl, n-decyl and n-dodecyl.
- For example, alkylene is preferably methylene, 1,1-ethylene, 1,2-ethylene, 1,1-propylene, 1,2-propylene, 1,3-propylene, 1,1-butylene, 1,2-butylene, 2,3-butylene and 1,4-butylene, 1,5-pentylene, 1,6-hexylene, 1,1-cyclohexylene, 1,4-cyclohexylene, 1,2-cyclohexylene and 1,8-octylene.
- For example, alkoxy is preferably methoxy, ethoxy, isopropoxy, n-propoxy, n-butoxy, tert-butoxy and cyclohexyloxy.
- For the purposes of the present invention, arylalkyl is preferably, unless indicated individually, in each case independently, a straight-chain, cyclic, branched or unbranched alkyl radical which may be monosubstituted or polysubstituted, more preferably monosubstituted, by aryl radicals as defined above.
- For the purposes of the present invention, haloalkyl or haloalkylene is preferably, unless indicated individually, in each case independently, a straight-chain, cyclic, branched or unbranched alkyl radical which may be monohalogenated, polyhalogenated or perhalogenated by halogen atoms selected independently from the group consisting of fluorine, chlorine, bromine and iodide.
- For example, C1-C8-haloalkyl is preferably trifluoromethyl, trichloromethyl, 2,2,2-trifluoroethyl, pentafluoroethyl and nonafluorobutyl; C1-C8-fluoroalkyl is trifluoromethyl, 2,2,2-trifluoroethyl, pentafluoroethyl and nonafluorobutyl.
- Protected formyl is a formyl radical which is protected by conversion into an aminal, acetal or a mixed aminal-acetal, with the aminals, acetals and mixed aminal-acetals being able to be acyclic or cyclic.
- Preferred compounds of the formulae (I), (IV), (V) and (VII) are defined below.
- In the formula (I), R1, R2, R3 and R4 are each preferably, independently of one another, hydrogen, C1-C8-alkyl, C5-C14-aryl, C6-C15-arylalkyl, C1-C8-haloalkyl or two of the radicals R1, R2, R3 and R4 are together part of a 3- to 7-membered ring having a total of from 3 to 16 carbon atoms.
- More preference is given to compounds in which at least one, even more preferably at least two, radicals R1, R2, R3 and R4 are hydrogen.
- In the formula (IV), R8 is preferably hydrogen or C3-C6-alkyl, more preferably hydrogen or tert-butyl and most preferably hydrogen.
- In the formula (V), R9 is preferably hydrogen, halogen, C1-C4-alkoxy, C1-C4-alkyl, phenyl, more preferably hydrogen or phenyl.
- Furthermore, L1 and L2 in the formula (V) are identical radicals of the formula (VI-a) or (VI-b).
- Preference is given to the radicals R10a and/or R10b each being, independently of one another, hydrogen, methyl or phenyl. Particular preference is given to in each case one of the radicals R10a and/or R10b being methyl or phenyl and the second radical R10a and/or R10b and, if applicable, the two other radicals R10a or R10b being hydrogen, or one radical R10a being hydrogen and the second radical R10a together with R11 forming an indanediyl group. More preferably, R10a in the formula (VI-a) and R10a and R10b in the formula (VI-b) are each hydrogen.
- The radical R11 is preferably methyl, isopropyl, tert-butyl, 2-naphthyl, phenyl, 2-chlorophenyl, benzyl, hydroxymethyl, tributylsiloxymethyl, 2-tributylsiloxyethyl or methoxycarbonyl.
- In compounds of the formula (VII), R12 is preferably hydrogen, hydroxy, C1-C4-alkoxy or phenyl, more preferably hydrogen.
- Preference is given to at least two, preferably three, of the radicals X1, X2, X3 being CH or CR12.
- n is preferably 0 or 1 and more preferably denotes one substitutent in the 4 position.
- Preferred ruthenium complexes are complexes of the formula (VIII)
-
[Ru(V)(VII)] (VIII) - where (V) denotes a compound of the formula (V) and (VII) denotes a compound of the formula (VII). Such complexes can be prepared in a manner known per se by methods analogous to those described in the references cited at the outset.
- Compounds of the formula (V) are, with the exception of compounds in which L1 and L2 are each a radical of the formula (VI-a), where the radicals R10a are each hydrogen and R11 is isopropyl or phenyl, previously unknown and are therefore encompassed by the present invention. The same applies to the ruthenium complexes which are used in the process of the invention and are derived from such compounds of the formula (V), such as ruthenium complexes of the formula (VIII).
- Examples of such compounds of the formula (V) are 4-Chloro-2,6-bis[4′-(S)-phenyloxazolin-2′-yl]pyridine, 4-phenyl-2,6-bis[4′-(S)-phenyl-oxazolin-2′-yl]pyridine, 2,6-bis[(R)-4′-(1″-naphthyl)-5′,6′-dihydro-4′H-[1′,3′]oxazin-2′-yl]pyridine and 2,6-bis[(R)-4′-(2″-naphthyl)-5′,6′-dihydro-4′H-[1′,3′]oxazin-2′-yl]pyridine.
- Compounds of the formula (V) can be prepared, for example, by the method of Nishiyama et al., Organometallics 1991, 10, 500-508.
- Preferably, the process of the invention is carried out in the presence of organic solvents, in particular secondary or tertiary alcohols, aprotic polar solvents, ketones, chlorinated hydrocarbons and aromatic hydrocarbons. For the purposes of the present invention, aprotic polar solvents are solvents which have a dielectric constant at 25° C. of 5 or more and a pKa based on an aqueous reference scale at 25° C. of 20 or more. Particular preference is given to using secondary and tertiary alcohols, in particular t-amyl alcohol and t-butyl alcohol, in the process of the invention.
- The reaction is, for example, carried out by placing the compounds of the formula (III) and the ruthenium complex and, if appropriate, an additive together with an organic solvent in a reaction vessel and adding the oxidant, if appropriate as a solution in a suitable organic solvent. In a preferred embodiment, a solution of the oxidant is metered into the reaction mixture over a period of from 10 minutes to 24 hours.
- The reaction time (further stirring time) can be, for example, up to 24 hours, preferably up to 5 hours and preferably up to 2 hours.
- The reaction can be carried out at temperatures of from −20° C. to 150° C., preferably from 0 to 80° C., more preferably from 0° C. to 40° C., and most preferably from 15° C. to 30° C.
- The pressure in the reaction is not critical and can be, for example, from 0.5 to 100 bar, preferably from 0.8 to 10 bar. More preference is given to ambient pressure.
- As compounds of the formula (IV), preference is given to using tert-butyl hydroperoxide or hydrogen peroxide in the process of the invention. The oxidant is preferably used in an amount of from 1 to 10 molar equivalents based on compounds of the formula (III), more preferably from 1 to 5 molar equivalents and most preferably from 1 to 3 molar equivalents. It may be advantageous to use the oxidant as a solution in a solvent, preferably as a solution in water.
- According to the process of the present invention, additives can be added to the reaction mixture. Examples of suitable additives include: amines, phosphites, phosphine oxides, N-methylmorpholine N-oxide, 2,2,6,6-tetramethylpiperidin-1-yl oxide, pyridines, pyridine N-oxide, imidazoles, quinoline, quinoline N-oxide, 2,2′-bipyridyl, 2,2′-bipyridyl N,N′-dioxide, ammonium salts, aromatic and aliphatic carboxylic acids, carboxylic anhydrides, (R)- or (S)-alkanesulfinamides and aromatic alcohols. These additives are preferably used in an amount of from 5 to 100 mol % based on compounds of the formula (III), more preferably from 10 to 50 mol % and very most preferably 20 mol %.
- For the purposes of the present invention, the ruthenium complex can either be used as an isolated complex or be generated in situ in the reaction mixture. In the latter case, a suitable ruthenium precursor
- complex, e.g. [Ru(p-cymene)Cl2]2, and the two ligands of the formulae (V) and (VII) are combined in the reaction mixture.
Isolated complexes are, for example, - [Ru(4-chloro-2,6-bis[4′-(S)-phenyloxazolin-2′-yl]pyridine)(pyridine-2,6-dicarboxylate)]
- [Ru(4-phenyl-2,6-bis[4′-(S)-phenyloxazolin-2-yl]pyridine) (pyridine-2,6-dicarboxylate)]
- [Ru(2,6-bis[4′-(S)-isopropyloxazoline-2′-yl]pyridine)(pyridine-2,6-dicarboxylate)]
- [Ru(2,6-bis[(R)-4′-phenyl-5′,6′-dihydro-4′H-[1′,3′]oxazin-2′-yl]pyridine)(pyridine-2,6-dicarboxylate)]
- [Ru(2,6-bis[(R)-4′-(1″-naphthyl)-5′,6′-dihydro-4′H-[1′,3′]oxazin-2′-yl]pyridine)(pyridine-2,6-dicarboxylate)]
- [Ru(2,6-bis[(R)-4′-(2″-naphthyl)-5′,6′-dihydro-4′H-[1′,3′]oxazin-2′-yl]pyridine)(pyridine-2,6-dicarboxylate)]
- The preparation of the isolated complexes is preferably likewise carried out by combining a suitable ruthenium precursor complex such as [Ru(p-cymene)Cl2]2, and the two ligands of the formulae (V) and (VIII) by, for example, introducing the ruthenium precursor complex with the ligand of the formula (V) into a suitable solvent in an inert gas atmosphere and adding a solution of the ligand of the formula (VII), subsequently heating the reaction mixture and isolating the ruthenium complex after work-up by means of extraction, drying and optionally subsequent chromatographic purification and/or recrystallization.
- For the purposes of the present invention, the amount of ruthenium complex used or of ruthenium precursor complex used is, for example, in the range from 0.01 to 20 mol %, preferably from 1 to 10 mol % and more preferably from 2 to 5 mol %.
- Compounds of the formula (I) can be obtained in good yields with high stereoisomeric or enantiomeric excesses in the manner prescribed by the invention. The work-up can be carried out in a known manner, e.g. by quenching with water, extraction with a suitable organic solvent and distillation or recrystallization of the epoxide.
- The compounds of the formula (I) which can be prepared according to the invention are particularly useful for preparing pharmaceuticals, agrochemicals, polymers or intermediates for these.
- In the process of the present invention, the asymmetric epoxidation of olefins proceeds with high chemoselectivity and enantioselectivity and gives very good product yields. At the same time, the ability to use the inexpensive oxidant hydrogen peroxide is a particular advantage.
- In a typical experiment, an olefin (0.5 mmol) and the ruthenium complex catalyst [Ru(S,S-2,6-bis[4′-(S)-phenyloxazolin-2′-yl]pyridine)(pyridine-2,6-dicarboxylate)] (0.025 mmol) were admixed with t-amyl alcohol (9 ml) and an additive was added if applicable. A solution of the oxidant (0.75 mmol) in t-amyl alcohol (1 ml) was metered into this mixture over a period of 12 hours. After the reaction was complete (monitoring of the conversion by GC-FID), the reaction mixture was quenched with saturated Na2SO3 solution (about 10 ml) and extracted twice with dichloromethane (10 ml each time). After removal of the solvent by distillation, the product was purified by column chromatography. All products described below were confirmed by GC-MS and NMR data and comparison with authentic samples (GC-FID).
- Use of trans-stilbene and H2O2 as oxidant in the general method gave trans-stilbene oxide in a yield of 99% and an ee of 67%.
- Use of trans-stilbene and H2O2 as oxidant in the presence of 0.025 mmol of 2,2′-bipyridyl N,N′-dioxide as additive in the general method gave stilbene oxide in a yield of 96% and an ee of 71%.
- Use of trans-stilbene and H2O2 as oxidant and the catalyst [Ru(4-chloro-2,6-bis[4′-(S)-phenyloxazolin-2′-yl]pyridine)(pyridine-2,6-dicarboxylate)] in the general method gave trans-stilbene oxide in a yield of 93% and an ee of 71%.
- Use of trans-stilbene and H2O2 as oxidant and the catalyst [Ru(4-phenyl-2,6-bis[4′-(S)-phenyloxazolin-2′-yl]pyridine) (pyridine-2,6-dicarboxylate)] (0.025 mmol) in the general method gave trans-stilbene oxide in a yield of 97% and an ee of 69%.
- Use of trans-stilbene and H2O2 as oxidant and the catalyst [Ru(2,6-bis[4′-(S)-isopropyloxazolin-2′-yl]pyridine)(pyridine-2,6-dicarboxylate)] (0.025 mmol) in the general method gave trans-stilbene oxide in a yield of 100% and an ee of 54%.
- Use of styrene and H2O2 as oxidant in a procedure analogous to Example 1 gave styrene oxide in a yield of 71% and an ee of 31%.
- Use of styrene and H2O2 as oxidant and acetic acid in a procedure analogous to Example 1 gave styrene oxide in a yield of 75% and an ee of 42%.
- Use of p-chlorostyrene and t-BuOOH as oxidant in a procedure analogous to Example 1 gave p-chlorostyrene oxide in a yield of 48% and an ee of 34%.
- Use of p-fluorostyrene and t-BuOOH as oxidant in a procedure analogous to Example 1 gave p-fluorostyrene oxide in a yield of 54% and an ee of 34%.
- Use of α-methylstyrene and H2O2 as oxidant in a procedure analogous to Example 1 gave α-methylstyrene oxide in a yield of 52% and an ee of 13%.
- Use of β-methylstyrol and H2O2 as oxidant in a procedure analogous to Example 1 gave β-methylstyrene oxide in a yield of 82% and an ee of 58%.
- Use of 2-methyl-1-phenyl-1-propene and t-BuOOH as oxidant in a procedure analogous to Example 1 gave 2-methyl-1-phenyl-1-propene oxide in a yield of 95% and an ee of 65%.
- Use of 1,2-diphenyl-1-propene and t-BuOOH as oxidant in the general method gave 1,2-diphenyl-1-propene oxide in a yield of 93% and an ee of 22%.
- Use of triphenylethylene and t-BuOOH as oxidant in a procedure analogous to Example 1 gave triphenylethylene oxide in a yield of 90% and an ee of 8%.
- Use of 1-phenylcyclohexene and H2O2 as oxidant in a procedure analogous to Example 1 gave 1-phenylcyclohexene oxide in a yield of 87% and an ee of 12%.
- Use of trans-stilbene and H2O2 as oxidant in a procedure analogous to Example 1, but with generation of the catalyst in situ from 0.0125 mol of [Ru(p-cymene)Cl2]2, 0.025 mol of 2,6-bis[4′-(S)-phenyloxazolin-2′-yl]pyridine and 0.025 mol of disodium pyridine-2,6-dicarboxylate, gave trans-stilbene oxide in a yield of 96% and an ee of 61%.
-
TABLE 1 Tabular summary of Examples 1 to 16 of the asymmetric epoxidation of olefins in the presence of ruthenium complexes Yield ee Ex. Olefin Oxidant Additive Catalyst [%] [%] 1 H2O2 — R11 = Ph; R9 = H; R12 = H 99 67 2 H2O2 5 mol % of 2,2′- bipyri- dyl N,N′- oxide R11 = Ph; R9 = H; R12 = H 96 71 3 H2O2 — R11 = Ph; R9 = Cl; R12 = H 93 71 4 H2O2 — R11 = Ph; R9 = Ph; R12 = H 97 69 5 H2O2 — R11 = i-Pr; R12 = R9 = H 100 54 6 H2O2 — R11 = Ph; R12 = R9 = H 71 31 7 H2O2 20 mol % of acetic acid R11 = Ph; R12 = R9 = H 75 42 8 t-BuOOH — R11 = Ph; R12 = R9 = H 48 34 9 t-BuOOH — R11 = Ph; R12 = R9 = H 54 34 10 H2O2 — R11 = Ph; R12 = R9 = H 52 13 11 H2O2 — R11 = Ph; R12 = R9 = H 82 58 12 t-BuOOH — R11 = Ph; R12 = R9 = H 95 65 13 t-BuOOH — R11 = Ph; R12 = R9 = H 93 22 14 t-BuOOH — R11 = Ph; R12 = R9 = H 90 8 15 H2O2 — R11 = Ph; R12 = R9 = H 87 12 16 H2O2 — R11 = Ph R12 = R9 = H; in situ generation. 96 61 - Use of styrene and H2O2 as oxidant and the catalyst [Ru(2,6-bis[(R)-4′-phenyl-5′,6′-dihydro-4′H-[1′,3′]oxazin-2′-yl]pyridine)(pyridine-2,6-dicarboxylate)] (0.025 mmol) in the general method gave styrene oxide in a yield of 56% and an ee of 48%.
- Use of styrene and H2O2 as oxidant and the catalyst [Ru(2,6-bis[(R)-4′-(1″-naphthyl)-5′,6′-dihydro-4′H-[1′,3′]oxazin-2′-yl]pyridine)(pyridine-2,6-dicarboxylate)] (0.025 mmol) in the general method gave styrene oxide in a yield of 65% and an ee of 38%.
-
- A solution of 64 mg of disodium pyridine-2,6-dicarboxylate (0.30 mmol) in 2 ml of a mixture of methanol/water (1:1) was added dropwise under an Ar atmosphere to a solution of 150 mg of 2,6-bis[(R)-4′-(2″-naphthyl)-5′,6′-dihydro-4′H-[1′,3′]oxazin-2′-yl]pyridine (0.30 mmol) and 92 mg of [Ru(p-cymene)Cl2]2 (0.15 mmol) in 2 ml of methanol and the reaction mixture was heated at 65° C. for 1 hour. The reaction mixture was subsequently extracted with 30 ml of CH2Cl2, the organic phase was washed with 30 ml of water, dried over MgSO4, filtered and the solvent was removed under reduced pressure. After subsequent chromatography over silica gel (70-230 mesh) using CH2Cl2/methanol (from 100:2 to 100:5) as gradated eluent and renewed removal of the solvent under reduced pressure, the product was recrystallized from CH2Cl2/n-hexane. This gave 138 mg of [Ru(2,6-bis[(R)-4′-(2″-naphthyl)-5′,6′-dihydro-4′H-[1′,3′]oxazin-2′-yl]pyridine) (pyridine-2,6-dicarboxylate)] (60% of theory).
- Use of styrene and H2O2 as oxidant and the catalyst [Ru(2,6-bis[(R)-4′-(2″-naphthyl)-5′,6′-dihydro-4′H-[1′,3′]oxazin-2′-yl]pyridine)(pyridine-2,6-dicarboxylate)] (0.025 mmol) in the general method gave styrene oxide in a yield of 59% and an ee of 48%.
- Although the invention has been described in detail in the foregoing for the purpose of illustration, it is to be understood that such detail is solely for that purpose and that variations can be made therein by those skilled in the art without departing from the spirit and scope of the invention except as it may be limited by the claims.
Claims (9)
1. Compounds according to formula (V) comprising:
wherein R9 is hydrogen, halogen, hydroxy, alkoxy, hydroxycarbonyl, alkoxycarbonyl, alkyl, arylalkyl or aryl and
L1 and L2 are each, independently of one another, a radical of the formula (VI)
wherein “*1” is an asymmetric carbon atom in the (R) or (S) configuration and “*2” can likewise be such a carbon atom, the arrow points to the point of bonding to the central pyridine ring and each R10 and R11 are each, independently of one another, alkyl, alkoxyalkyl, trialkylsiloxyalkyl, alkoxycarbonyl, arylalkyl or aryl or one R10 and R11 are part of a cyclic radical having a total of from 5 to 16 carbon atoms and the other R10 is hydrogen said compound not including those radicals where L1 and L2 are radicals where both R10 are each hydrogen and R11 is isopropyl or phenyl.
2. Compounds according to claim 1 consisting of those selected from 4-Chloro-2,6-bis[4′-(S)-phenyloxazolin-2′-yl]pyridine, 4-phenyl-2,6-bis[4′-(S)-phenyl-oxazolin-2′-yl]pyridine, 2,6-bis[(R)-4′-(1″-naphthyl)-5′,6′-dihydro-4′H-[1′,3′]oxazin-2′-yl]pyridine, and 2,6-bis[(R)-4′-(2″-naphthyl)-5′,6′-dihydro-4′H-[1′,3′]oxazin-2′-yl]-pyridine.
3. Ruthenium complexes comprising compounds of the formula (V) according to claim 1 .
4. Ruthenium complexes according to claim 3 consisting of those selected from 4-Chloro-2,6-bis[4′-(S)-phenyloxazolin-2′-yl]pyridine, 4-phenyl-2,6-bis[4′-(S)-phenyloxazolin-2′-yl]pyridine, 2,6-bis[(R)-4′-(1″-naphthyl)-5′,6′-dihydro-4′H-[1′,3′]oxazin-2′-yl]pyridine, and 2,6-bis[(R)-4′-(2″-naphthyl)-5′,6′-dihydro-4′H-[1′,3′]oxazin-2′-yl]pyridine.
5. Method of for preparing pharmaceuticals, agrochemicals, polymers or intermediates comprising preparing said pharmaceuticals, agrochemicals, polymer or intermediates by using compounds of the formula (I)
wherein
“*” is a carbon atom having an (R) or (S) configuration and R1, R2, R3 and R4 are each, independently of one another, hydrogen, alkyl, aryl, arylalkyl, haloalkyl or a radical of one of formulae (IIa) to (IIf)
A-B-D-E (IIa)
A-E (IIb)
A-SO2-E (IIc)
A-B-SO2R6 (IId)
A-SO3W (IIe)
A-COW (IIf)
A-B-D-E (IIa)
A-E (IIb)
A-SO2-E (IIc)
A-B-SO2R6 (IId)
A-SO3W (IIe)
A-COW (IIf)
wherein, in the formulae (IIa) to (IIf)
A is absent or is an alkylene or haloalkylene radical and
B is absent or is oxygen or NR5, where
R5 is nitrogen, arylalkyl or aryl, and
D is a carbonyl group and
E is R6, OR6, NHR7 or N(R7)2,
wherein
R6 is alkyl, arylalkyl or aryl and the radicals R7 are each, independently of one another, alkyl, arylalkyl or aryl or the moiety N(R7)2 is a cyclic amino radical having from 4 to 12 carbon atoms and
W is OH, NH2, or OM,
where M is an alkali metal ion, half an equivalent of an alkaline earth metal ion, an ammonium ion or an organic ammonium ion, or two of the radicals R1, R2, R3 and R4 are together part of a 3- to 7-membered ring having a total of from 3 to 16 carbon atoms,
wherein compounds of formula (I) are prepared by reacting compounds of the formula (III),
where R1, R2, R3 and R4 are each, independently of one another, as defined above,
with compounds of the formula (IV),
R8—OOH (IV)
R8—OOH (IV)
wherein R8 is hydrogen, alkyl or arylalkyl,
in the presence of a ruthenium complex which bears as ligands both compounds of the formula (V)
wherein R9 is hydrogen, halogen, hydroxy, alkoxy, hydroxycarbonyl, alkoxycarbonyl, alkyl, arylalkyl or aryl and
L1 and L2 are each, independently of one another, a radical of the formula (VI)
wherein “*1” is an asymmetric carbon atom in the (R) or (S) configuration and “*2” can likewise be such a carbon atom, the arrow points to the point of bonding to the central pyridine ring and R10 and R11 are each, independently of one another, alkyl, alkoxyalkyl, trialkylsiloxyalkyl, alkoxycarbonyl, arylalkyl or aryl or R10 and R11 are part of a cyclic radical having a total of from 5 to 16 carbon atoms and R10 may also be hydrogen,
and compounds of the formula (VII)
6. A pharmaceutical comprising a compound of the formula (I) prepared according to claim 5 .
7. An agrochemical comprising a compound of the formula (I) prepared according to claim 5 .
8. A polymer comprising a compound of the formula (I) prepared according to claim 5 .
9. An intermediate compound for a pharmaceutical, an agro chemical or a polymer comprising a compound of the formula (I) wherein the compound of formula (I) wherein compounds of formula (I):
wherein
“*” is a carbon atom having an (R) or (S) configuration and R1, R2, R3 and R4 are each, independently of one another, hydrogen, alkyl, aryl, arylalkyl, haloalkyl or a radical of one of formulae (IIa) to (IIf)
A-B-D-E (IIa)
A-E (IIb)
A-SO2-E (IIc)
A-B-SO2R6 (IId)
A-SO3W (IIe)
A-COW (IIf)
A-B-D-E (IIa)
A-E (IIb)
A-SO2-E (IIc)
A-B-SO2R6 (IId)
A-SO3W (IIe)
A-COW (IIf)
wherein, in the formulae (IIa) to (IIf)
A is absent or is an alkylene or haloalkylene radical and
B is absent or is oxygen or NR5, where
R5 is nitrogen, arylalkyl or aryl, and
D is a carbonyl group and
E is R6, OR6, NHR7 or N(R7)2,
wherein
R6 is alkyl, arylalkyl or aryl and
the radicals R7 are each, independently of one another, alkyl, arylalkyl or aryl or the moiety N(R7)2 is a cyclic amino radical having from 4 to 12 carbon atoms and
W is OH, NH2, or OM,
where M is an alkali metal ion, half an equivalent of an alkaline earth metal ion, an ammonium ion or an organic ammonium ion, or two of the radicals R1, R2, R3 and R4 are together part of a 3- to 7-membered ring having a total of from 3 to 16 carbon atoms,
are prepared by reacting compounds of the formula (III),
where R1, R2, R3 and R4 are each, independently of one another, as defined above,
with compounds of the formula (IV),
R8—OOH (IV)
R8—OOH (IV)
wherein R8 is hydrogen, alkyl or arylalkyl,
in the presence of a ruthenium complex which bears as ligands both compounds of the formula (V)
wherein R9 is hydrogen, halogen, hydroxy, alkoxy, hydroxycarbonyl, alkoxycarbonyl, alkyl, arylalkyl or aryl and
L1 and L2 are each, independently of one another, a radical of the formula (VI)
wherein “*1” is an asymmetric carbon atom in the (R) or (S) configuration and “*2” can likewise be such a carbon atom, the arrow points to the point of bonding to the central pyridine ring and R10 and R11 are each, independently of one another, alkyl, alkoxyalkyl, trialkylsiloxyalkyl, alkoxycarbonyl, arylalkyl or aryl or R10 and R11 are part of a cyclic radical having a total of from 5 to 16 carbon atoms and R10 may also be hydrogen,
and compounds of the formula (VII)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/464,933 US20090221816A1 (en) | 2004-02-05 | 2009-05-13 | Process for the Asymmetric Epoxidation of Olefins |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004005725 | 2004-02-05 | ||
DE102004005724.7 | 2004-02-05 | ||
DE102004024709.9 | 2004-05-19 | ||
DE102004024709A DE102004024709A1 (en) | 2004-02-05 | 2004-05-19 | Preparation of stereoisomerically enriched oxiranes, useful e.g. in preparation of pharmaceuticals and agricultural chemicals, by reacting olefin with oxidizing agent in presence of specific ruthenium catalysts |
US11/051,279 US7544819B2 (en) | 2004-02-05 | 2005-02-04 | Process for the asymmetric epoxidation of olefins |
US12/464,933 US20090221816A1 (en) | 2004-02-05 | 2009-05-13 | Process for the Asymmetric Epoxidation of Olefins |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/051,279 Division US7544819B2 (en) | 2004-02-05 | 2005-02-04 | Process for the asymmetric epoxidation of olefins |
Publications (1)
Publication Number | Publication Date |
---|---|
US20090221816A1 true US20090221816A1 (en) | 2009-09-03 |
Family
ID=34680172
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/051,279 Expired - Fee Related US7544819B2 (en) | 2004-02-05 | 2005-02-04 | Process for the asymmetric epoxidation of olefins |
US12/464,933 Abandoned US20090221816A1 (en) | 2004-02-05 | 2009-05-13 | Process for the Asymmetric Epoxidation of Olefins |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/051,279 Expired - Fee Related US7544819B2 (en) | 2004-02-05 | 2005-02-04 | Process for the asymmetric epoxidation of olefins |
Country Status (4)
Country | Link |
---|---|
US (2) | US7544819B2 (en) |
EP (1) | EP1561750A1 (en) |
CN (2) | CN1680345A (en) |
DE (1) | DE102004024709A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102005002821A1 (en) * | 2005-01-20 | 2006-08-03 | Lanxess Deutschland Gmbh | Preparation of propoxy compounds comprises reaction of alkene compounds with hydrogen peroxide in the presence of ruthenium complex |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4943644A (en) * | 1988-01-22 | 1990-07-24 | The University Of Florida | Olefin and alkane oxidations, ruthenium carboxylate catalyst therefor and method of preparation thereof |
US5969166A (en) * | 1904-12-09 | 1999-10-19 | Hoechst Aktiengesellschaft | Epoxides produced by the oxidation of olefins with air or oxygen |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4447232A1 (en) * | 1994-12-30 | 1996-07-04 | Hoechst Ag | Selective catalysts for epoxidation of alkene(s) with atmos. oxygen@ |
-
2004
- 2004-05-19 DE DE102004024709A patent/DE102004024709A1/en not_active Withdrawn
-
2005
- 2005-02-04 EP EP05002337A patent/EP1561750A1/en not_active Withdrawn
- 2005-02-04 US US11/051,279 patent/US7544819B2/en not_active Expired - Fee Related
- 2005-02-05 CN CNA2005100091834A patent/CN1680345A/en active Pending
- 2005-02-05 CN CNA2006100913208A patent/CN1869029A/en active Pending
-
2009
- 2009-05-13 US US12/464,933 patent/US20090221816A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5969166A (en) * | 1904-12-09 | 1999-10-19 | Hoechst Aktiengesellschaft | Epoxides produced by the oxidation of olefins with air or oxygen |
US4943644A (en) * | 1988-01-22 | 1990-07-24 | The University Of Florida | Olefin and alkane oxidations, ruthenium carboxylate catalyst therefor and method of preparation thereof |
Also Published As
Publication number | Publication date |
---|---|
CN1869029A (en) | 2006-11-29 |
US7544819B2 (en) | 2009-06-09 |
US20050203303A1 (en) | 2005-09-15 |
CN1680345A (en) | 2005-10-12 |
DE102004024709A1 (en) | 2005-09-15 |
EP1561750A1 (en) | 2005-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Schwarz et al. | 1, 2-Amino alcohols via Cr/photoredox dual-catalyzed addition of α-amino carbanion equivalents to carbonyls | |
US8586742B2 (en) | Process for preparing amines from alcohols and ammonia | |
Schurig et al. | Metal-mediated enantioselective access to unfunctionalized aliphatic oxiranes: prochiral and chiral recognition | |
Bandini et al. | The First Catalytic Enantioselective Nozaki–Hiyama Reaction | |
Illa et al. | Practical and highly selective sulfur ylide-mediated asymmetric epoxidations and aziridinations using a cheap and readily available chiral sulfide: Extensive studies to map out scope, limitations, and rationalization of diastereo-and enantioselectivities | |
US5665890A (en) | Stereoselective ring opening reactions | |
Vazdar et al. | Design of novel uncharged organic superbases: Merging basicity and functionality | |
Schoumacker et al. | Catalytic asymmetric sulfoxidation by chiral manganese complexes: acetylacetonate anions as chirality switches | |
Sohtome et al. | Linking Conformational Flexibility and Kinetics: Catalytic 1, 4‐Type Friedel–Crafts Reactions of Phenols Utilizing 1, 3‐Diamine‐Tethered Guanidine/Bisthiourea Organocatalysts | |
Zwettler et al. | Oxidorhenium (V) complexes with tetradentate iminophenolate ligands: influence of ligand flexibility on the coordination motif and oxygen-atom-transfer activity | |
Musina et al. | Dynamic covalent chemistry approach toward 18-membered P4N2 macrocycles and their nickel (II) complexes | |
KR101839877B1 (en) | New organocatalysts and method of manufacturing alkylene carbonates using the same | |
US20090221816A1 (en) | Process for the Asymmetric Epoxidation of Olefins | |
Protesescu et al. | Unusual behavior of a novel heterogeneous chiral dimer Cr (III)− Salen complex in the epoxidation/epoxide ring-opening reaction of trans-methylcinnamate ester | |
Luo et al. | One-pot production of chiral α, β-epoxy ketones from benzaldehydes and acetophenones by recyclable poly (amino acid) catalysis | |
EP1263735B1 (en) | Acid addition salts of imidazolidinones as reaction catalysts | |
Suresh et al. | Synthesis of new binol based [1+ 1] macrocyclic chiral manganese (III) Schiff bases as catalysts for asymmetric epoxidation | |
Manßen et al. | Accessing secondary amine containing fine chemicals and polymers with an earth-abundant hydroaminoalkylation catalyst | |
Neves et al. | Performance of chiral tetracarbonylmolybdenum pyrindanyl amine complexes in catalytic olefin epoxidation | |
Wu et al. | Asymmetric organocatalytic Michael addition of anthrone to enone | |
Trost et al. | Enantioselective synthesis of cyanohydrins by a novel aluminum catalyst | |
JP4357332B2 (en) | Process for producing optically active nitroalcohols | |
JP6213999B2 (en) | Amine compound, optically active amine, asymmetric catalyst containing optically active amine, and method for producing optically active halogen compound using asymmetric catalyst | |
US10487100B1 (en) | Macrocyclic ligands and their complexes for bifunctional molecular catalysis | |
US8236976B2 (en) | Processes for highly enantio- and diastereoselective synthesis of acyclic epoxy alcohols and allylic epoxy alcohols |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: LANXESS DEUTSCHLAND GMBH, GERMANY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MAEGERLEIN, WOLFGANG;BELLER, MATTHIAS;DOEBLER, CHRISTIAN;AND OTHERS;REEL/FRAME:022675/0240;SIGNING DATES FROM 20050314 TO 20050411 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |